Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2025

SELL
$96.76 - $112.03 $14.5 Million - $16.8 Million
-149,627 Closed
0 $0
Q2 2022

Oct 27, 2025

SELL
$102.07 - $123.37 $52.7 Million - $63.7 Million
-516,665 Reduced 77.54%
149,627 $16.3 Billion
Q1 2022

Oct 27, 2025

SELL
$114.02 - $139.04 $4.8 Million - $5.85 Million
-42,090 Reduced 5.94%
666,292 $78.9 Billion
Q4 2021

Oct 27, 2025

SELL
$115.53 - $141.46 $1.52 Million - $1.87 Million
-13,185 Reduced 1.83%
708,382 $99.7 Billion
Q3 2021

Oct 27, 2025

SELL
$116.66 - $129.06 $18.6 Million - $20.6 Million
-159,245 Reduced 18.08%
721,567 $85.2 Billion
Q2 2021

Oct 27, 2025

BUY
$105.79 - $124.53 $24.5 Million - $28.8 Million
231,235 Added 35.6%
880,812 $102 Billion
Q1 2021

Oct 27, 2025

BUY
$108.84 - $128.23 $17.4 Million - $20.6 Million
160,320 Added 32.77%
649,577 $77.8 Billion
Q4 2020

Oct 27, 2025

SELL
$105.0 - $114.42 $6.17 Million - $6.72 Million
-58,715 Reduced 10.71%
489,257 $53.6 Billion
Q3 2020

Oct 27, 2025

BUY
$91.64 - $111.29 $24.3 Million - $29.5 Million
264,740 Added 93.47%
547,972 $59.6 Billion
Q2 2020

Oct 27, 2025

BUY
$76.57 - $98.0 $154,288 - $197,470
2,015 Added 0.72%
283,232 $25.9 Billion
Q1 2020

Oct 27, 2025

SELL
$62.82 - $91.86 $2.88 Million - $4.21 Million
-45,809 Reduced 14.01%
281,217 $22.2 Billion
Q4 2019

Oct 27, 2025

BUY
$78.51 - $87.4 $8.95 Million - $9.97 Million
114,026 Added 53.53%
327,026 $28.4 Billion
Q3 2019

Oct 27, 2025

BUY
$81.84 - $88.74 $17.4 Million - $18.9 Million
213,000 New
213,000 $17.8 Billion
Q2 2019

Oct 28, 2025

BUY
$72.88 - $85.0 $1.87 Million - $2.18 Million
25,600 Added 19.96%
153,850 $12.9 Billion
Q1 2019

Oct 28, 2025

BUY
$66.22 - $80.06 $8.49 Million - $10.3 Million
128,250 New
128,250 $10.3 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Munro Partners Portfolio

Follow Munro Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Munro Partners, based on Form 13F filings with the SEC.

News

Stay updated on Munro Partners with notifications on news.